Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2006 2
2007 3
2008 2
2009 2
2010 3
2011 2
2012 2
2013 6
2014 8
2015 2
2016 5
2017 3
2018 10
2019 5
2020 5
2021 5
2022 8
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic Value of Liquid-Biopsy-Based Biomarkers in Upper Tract Urothelial Carcinoma.
Padullés B, Carrasco R, Ingelmo-Torres M, Roldán FL, Gómez A, Vélez E, Alfambra H, Figueras M, Carrion A, Gil-Vernet J, Mengual L, Izquierdo L, Alcaraz A. Padullés B, et al. Among authors: mengual l. Int J Mol Sci. 2024 Mar 26;25(7):3695. doi: 10.3390/ijms25073695. Int J Mol Sci. 2024. PMID: 38612507 Free PMC article.
Assessment of aggressive bladder cancer mutations in plasma cell-free DNA.
Carrasco R, Ingelmo-Torres M, Oriola J, Roldán FL, Rodríguez-Carunchio L, Herranz S, Mellado B, Alcaraz A, Izquierdo L, Mengual L. Carrasco R, et al. Among authors: mengual l. Front Oncol. 2023 Nov 30;13:1270962. doi: 10.3389/fonc.2023.1270962. eCollection 2023. Front Oncol. 2023. PMID: 38098507 Free PMC article.
Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol 2023;83:313-17].
Gil-Jimenez A, van Dorp J, Contreras-Sanz A, van der Vos K, Vis DJ, Braaf L, Broeks A, Kerkhoven R, van Kessel KEM, Ribal MJ, Alcaraz A, Wessels LFA, Seiler R, Wright JL, Mengual L, Boormans J, van Rhijn BWG, Black PC, van der Heijden MS. Gil-Jimenez A, et al. Among authors: mengual l. Eur Urol. 2023 Jun;83(6):e165. doi: 10.1016/j.eururo.2023.03.002. Epub 2023 Mar 10. Eur Urol. 2023. PMID: 36907692 No abstract available.
Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patients.
Mengual L, Frantzi M, Mokou M, Ingelmo-Torres M, Vlaming M, Merseburger AS, Roesch MC, Culig Z, Alcaraz A, Vlahou A, Mischak H, Van der Heijden AG. Mengual L, et al. Br J Cancer. 2022 Nov;127(11):2043-2051. doi: 10.1038/s41416-022-01992-3. Epub 2022 Oct 3. Br J Cancer. 2022. PMID: 36192490 Free PMC article.
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer.
Gil-Jimenez A, van Dorp J, Contreras-Sanz A, van der Vos K, Vis DJ, Braaf L, Broeks A, Kerkhoven R, van Kessel KEM, Ribal MJ, Alcaraz A, Wessels LFA, Seiler R, Wright JL, Mengual L, Boormans J, van Rhijn BWG, Black PC, van der Heijden MS. Gil-Jimenez A, et al. Among authors: mengual l. Eur Urol. 2023 Apr;83(4):313-317. doi: 10.1016/j.eururo.2022.07.023. Epub 2022 Aug 11. Eur Urol. 2023. PMID: 35965206
Prognostic Gene Expression-Based Signature in Clear-Cell Renal Cell Carcinoma.
Roldán FL, Izquierdo L, Ingelmo-Torres M, Lozano JJ, Carrasco R, Cuñado A, Reig O, Mengual L, Alcaraz A. Roldán FL, et al. Among authors: mengual l. Cancers (Basel). 2022 Aug 1;14(15):3754. doi: 10.3390/cancers14153754. Cancers (Basel). 2022. PMID: 35954418 Free PMC article.
70 results